| "Specializing in the integration and optimization of scientific and corporate decision-making processes related to toxicology in the pharmaceutical, chemical, and agrochemical industries" |
|
|
 |
Phenotypic Analysis of Genetically Altered Mice
- Evaluate genetic alteration and recommend optimized approach based on anticipated tissue/organ effects
- Design protocols for methods required (histology, immunohistochemistry, clinical chemistry, hematology, etc.)
- Review, correlate, and interpret findings
- Prepare summary report with recommendations for path forward
Benefit: A complete understanding of how the genetic alteration impacts organs increases the predictive value regarding therapeutic potential as well as potential toxicities
| Characterization of Animal Models of Human Disease |
|
- Evaluate animal models for diseases such as osteoarthritis, asthma, and cancer and recommend optimized approach to assessment
- Review methods of model generation to anticipate inherent complications to interpretation
- Design protocols for methods required (histology, histochemical stains, clinical chemistry, hematology, etc.)
- Review, correlate and interpret findings
- Collaborate with investigators to integrate features of the model with pharmacologic and/or behavioral endpoints
- Prepare summary report with recommendations for path forward
 |
Benefit: A complete understanding of the model relative to the actual human disease enhances decision making related to interpreting efficacy study findings |
| Design and Interpretation of Proof-of-Principle (POP) Studies |
|
- Develop with investigators a hypothesis-based study design using in vivo models
- Design protocols for required methods (histology, histochemical stains, clinical chemistry, hematology, etc).
- Review methods of model generation to anticipate inherent complications to interpretation
- Review, correlate, and interpret findings
- Prepare summary report with recommendations for path forward
 |
Benefit: The accurate interpretation of well-developed POP studies empowers the decision making process for recommending a path forward into development |
| Evaluate RNA/Protein Expression in Target Tissues |
|
- Review target/receptor data and recommend optimized approach to assessment in human and/or animal organs based on anticipated expression patterns
- Evaluate expression patterns in slides and/or review reports using immunohistochemistry or in situ hybridization detection methods
- Review and interpret findings (versus artifacts or nonspecific tissue reactions) in relationship to pharmacology and/or toxicity
- Prepare summary report with recommendations for path forward
 |
Benefit: A clear understanding of RNA/protein tissue expression patterns related to therapeutic targets increases the predictive value regarding therapeutic potential as well as potential toxicities |
Evaluate Histochemistry, Ultrastructure,
or
Morphometry Data Sets |
|
- Discuss with investigators the objective of the study
- Critically review histology slides, micrographs, and/or reports using these methods
- Evaluate relevance of findings (versus artifacts or nonspecific tissue reactions) in relationship to pharmacology and/or toxicity
- Prepare summary report with recommendations for path forward
 |
Benefit: The accurate interpretation of special techniques data clarifies the mechanism of organ toxicity in relationship to pharmacology and/or toxicology, and possible human relevance |
 |
|
 |